What is Chandra Bhagat Pharma share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Chandra Bhagat Pharma?

The latest standalone P/E ratio of Chandra Bhagat Pharma as of 17-Dec-2024 is 32.05.

What is the P/B ratio of Chandra Bhagat Pharma?

The latest standalone P/B ratio of Chandra Bhagat Pharma as of 17-Dec-2024 is 1.77.

Chandra Bhagat Pharma Ltd - Stock Valuation and Financial Performance

Name: Chandra Bhagat Pharma
Brand: Chandra Bhagat Pharma

BSE: 542934 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Chandra Bhagat Pharm Share Price

₹65 0.00 0.00%
as on 17-Dec'24 16:59

DeciZen - make an informed investing decision on Chandra Bhagat Pharm

Based on:

Data

M-Cap below 100cr DeciZen not available

Chandra Bhagat Pharma stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

32.05

Market Cap:

49 Cr.

52-wk low:

52-wk high:

156.5

Is Chandra Bhagat Pharma Ltd an attractive stock to invest in?

1. Is Chandra Bhagat Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chandra Bhagat Pharma Ltd is a below average quality company.

2. Is Chandra Bhagat Pharma Ltd undervalued or overvalued?

The key valuation ratios of Chandra Bhagat Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Chandra Bhagat Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chandra Bhagat Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Chandra Bhagat Pharm:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	10.4%	12.6%	14.3%	17.6%	13.4%	7.2%	7.6%	8.8%	7.4%	8.2%	-
Value Creation Index ⓘ	-0.3	-0.1	0.0	0.3	0.0	-0.5	-0.5	-0.4	-0.5	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	61.1	79.8	89.8	97.1	106	94	70.7	94.1	120	221	221
Sales YoY Gr.	-	30.6%	12.5%	8.1%	9.5%	-11.6%	-24.8%	33.1%	27.2%	85%	-
Adj EPS ⓘ	10.2	8.4	5	3.6	1.4	0.6	0.6	1.9	1.3	1.3	2
YoY Gr.	-	-18%	-39.8%	-29.4%	-61.4%	-58.4%	1.8%	231%	-34.4%	4%	-
BVPS (₹) ⓘ	153	161.5	22.2	23.8	24.9	32.2	32.5	33.7	34.1	36.7	36.7
Adj Net Profit ⓘ	0.4	0.4	1.7	1.2	0.7	0.4	0.4	1.5	1	1	2
Cash Flow from Ops. ⓘ	0	0	-9	-6.2	4.1	-7.4	8.3	12.4	5.3	6.2	-
Debt/CF from Ops. ⓘ	0	0	-2.5	-3.5	7.7	-4	3.3	1.7	3.6	2.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	15.4%	15.8%	46.3%	85%
Adj EPS ⓘ	-20.4%	-0.9%	31.2%	4%
BVPSⓘ	-14.7%	8.1%	4.1%	7.6%
Share Price	-	-	-10.8%	-50.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	6.9	5.3	23.8	15	6.4	2.1	1.7	5.5	3.5	3.5	5.5
Op. Profit Mgn % ⓘ	4.9	5.4	6.5	5.1	4.4	3.5	5.7	3.9	2.7	-3.3	NAN
Net Profit Mgn % ⓘ	0.7	0.4	1.9	1.2	0.7	0.5	0.6	1.5	0.8	0.5	0.7
Debt to Equity ⓘ	4.3	4.4	3	2.7	2.3	1.2	1.1	0.8	0.7	0.6	-
Working Cap Days ⓘ	188	172	181	198	227	289	360	256	177	119	0
Cash Conv. Cycle ⓘ	139	130	121	122	133	163	202	161	122	57	0

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 5.50%

Sales growth is growing at healthy rate in last 3 years 46.30%

Net Profit is growing at healthy rate in last 3 years 31.20%

Debt to equity has declined versus last 3 years average to 0.59

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Chandra Bhagat Pharma Ltd.

	Standalone	Consolidated
TTM EPS (₹)	2	-
TTM Sales (₹ Cr.)	221	-
BVPS (₹.) ⓘ	36.7	-
Reserves (₹ Cr.) ⓘ	21	-
P/BV ⓘ	1.77	-
PE ⓘ	32.05	-

From the Market
52 Week Low / High (₹)	63.00 / 156.50
All Time Low / High (₹)	30.50 / 160.00
Market Cap (₹ Cr.)	49
Equity (₹ Cr.)	7.6
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Chandra Bhagat Pharm:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Chandra Bhagat Pharm

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Chandra Bhagat Pharm

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	61.13	79.84	89.79	97.06	106.28	93.98	70.70	94.08	119.67	221.37
Operating Expenses ⓘ	58.14	75.56	85.42	92.47	101.69	90.86	67.01	91.33	116.49	228.57
Manufacturing Costs	0	0.14	0.15	0.13	0.31	0.14	0.24	0.34	0.70	3.93
Material Costs	44.71	62.98	73.60	82.39	92.37	85.80	59.74	81.36	106.58	208.04
Employee Cost	7.05	7.31	5.64	5.02	4.53	2.25	1.85	1.52	1.32	2.18
Other Costs ⓘ	6.37	5.12	6.02	4.93	4.48	2.66	5.18	8.11	7.89	14.42
Operating Profit ⓘ	2.99	4.29	4.37	4.59	4.59	3.12	3.68	2.75	3.18	-7.20
Operating Profit Margin (%)	4.9%	5.4%	4.9%	4.7%	4.3%	3.3%	5.2%	2.9%	2.7%	-3.3%
Other Income ⓘ	0.31	0.39	0.49	0.67	0.44	0.44	0.48	1.62	0.29	11.33
Interest ⓘ	2.35	3.71	3.81	3.67	4.09	3.11	3.76	3.24	2.20	1.39
Depreciation ⓘ	0.26	0.24	0.14	0.06	0.05	0.03	0.12	0.04	0.11	0.49
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.69	0.72	0.91	1.53	0.89	0.42	0.28	1.10	1.16	2.26
Tax ⓘ	0.27	0.37	0.25	0.50	0.20	0.11	0.09	0.30	0.26	0.73
Profit After Tax	0.43	0.35	0.66	1.03	0.69	0.31	0.19	0.80	0.91	1.53
PAT Margin (%)	0.7%	0.4%	0.7%	1.1%	0.6%	0.3%	0.3%	0.8%	0.8%	0.7%
Adjusted EPS (₹)	1.3	1.1	2.0	3.1	1.3	0.4	0.3	1.1	1.2	2.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	6.40	6.75	7.41	8.44	14.45	25.69	25.88	26.68	27.48	29.01
Share Capital ⓘ	0.42	0.42	0.42	0.42	0.67	7.55	7.55	7.55	7.55	7.55
Reserves ⓘ	5.98	6.33	6.99	8.03	13.78	18.14	18.33	19.13	19.93	21.46
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	27.50	29.58	20.50	21.75	27.78	27.50	25.09	19.81	17.67	15.47
Long Term Debt	0	0	4.22	11.74	11.46	10.89	9.45	5.42	3.93	1.41
Short Term Debt	27.50	29.58	16.28	10.01	16.32	16.62	15.63	14.39	13.74	14.06
Trade Payables	5.29	5.66	16.27	15.48	29.70	12.49	12.85	2.67	3.10	13.23
Others Liabilities ⓘ	3.02	2.50	11.68	12.36	10.91	9.06	7.96	23.31	12.34	44.07
Total Liabilities ⓘ	42.20	44.49	55.87	58.04	82.84	74.74	71.78	72.46	60.58	101.78
Fixed Assets
Gross Block	0.87	0.69	0.70	1.23	1.24	1.24	1.26	1.13	1.50	3.78
Accumulated Depreciation	0	0	0.14	0.72	0.78	0.81	0.84	0.66	0.77	1.25
Net Fixed Assetsⓘ	0.87	0.69	0.55	0.51	0.46	0.44	0.42	0.47	0.73	2.52
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	4.64	1.05	4.03	0.75	0	0.22	0.11	0.13
Inventories	21.65	21.19	26.75	32.64	43.91	43.90	35.14	34.16	29.08	8.68
Trade Receivables	11.89	14.47	19.66	17.86	26.30	14.03	15.42	15	8.19	39.45
Cash Equivalents	5.05	4.68	0.58	0.55	0.48	0.05	2.82	5.68	6.44	4.96
Others Assetsⓘ	2.74	3.46	3.69	5.42	7.66	15.57	17.98	16.93	16.04	46.04
Total Assets ⓘ	42.20	44.49	55.87	58.04	82.84	74.74	71.78	72.46	60.58	101.78

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-9.03	-6.18	4.05	-7.41	8.33	12.40	5.26	6.18
PBT ⓘ	0.91	1.53	0.89	0.42	0.28	1.10	1.16	2.26
Adjustment ⓘ	3.17	3.13	3.82	2.69	3.46	3.03	2.29	1.87
Changes in Working Capital ⓘ	-12.86	-10.55	-0.18	-10.53	4.68	8.38	2.14	2.5
Tax Paid ⓘ	-0.25	-0.28	-0.47	0	-0.10	-0.11	-0.23	-0.46
Cash Flow From Investing Activity ⓘ	0.30	-0.36	-0.40	0.05	0.12	0.09	-0.06	-1.85
Capex	0	-0.02	-0.01	0	-0.02	-0.09	-0.37	-2.28
Net Investments	0	0	0	0	0	0	0	0
Others ⓘ	0.31	-0.34	-0.39	0.05	0.14	0.17	0.31	0.43
Cash Flow From Financing Activityⓘ	7.97	6.51	-3.73	6.94	-6.42	-9.62	-4.45	-5.80
Net Proceeds from Shares ⓘ	0	0	5.30	10.93	0	0	0	0
Net Proceeds from Borrowing ⓘ	11.31	9.67	-5.04	-0.93	-1.96	-5.30	-1.58	-4.41
Interest Paid ⓘ	-3.34	-3.16	-3.99	-3.06	-3.48	-3.08	-2.19	-1.39
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	-0.98	-1.25	-0.68	0
Net Cash Flow ⓘ	-0.75	-0.02	-0.08	-0.43	2.02	2.86	0.76	-1.48

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	6.89	5.38	9.33	13.44	6.46	1.67	0.78	3.19	3.54	5.73
ROCE (%)	10.4	12.62	14.34	17.58	13.4	7.16	7.63	8.83	7.37	8.22
Asset Turnover Ratio	1.66	1.84	1.79	1.7	1.51	1.19	0.96	1.3	1.8	2.73
PAT to CFO Conversion(x)	0	0	-13.68	-6	5.87	-23.9	43.84	15.5	5.78	4.04
Working Capital Days
Receivable Days	61	60	69	71	76	78	76	59	35	39
Inventory Days	111	98	97	112	131	171	204	134	96	31
Payable Days	42	32	54	70	89	90	77	35	10	14

Chandra Bhagat Pharma Ltd Stock News

Chandra Bhagat Pharma Ltd FAQs

What is the share price of Chandra Bhagat Pharm?

Company share prices are keep on changing according to the market conditions. The closing price of Chandra Bhagat Pharm on 17-Dec-2024 16:59 is ₹65.00.

What is the market cap of Chandra Bhagat Pharm?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Dec-2024 16:59 the market cap of Chandra Bhagat Pharm stood at ₹49.04.